Showing results (171-180 of 478) with videos related to
Sort By:
Pageof 48
Crohn'S & Colitis 360|February 13, 2023
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving TherapyAjit Sood, Arshdeep Singh, Vandana Midha, et al.Inflammatory Bowel Diseases|January 13, 2024
Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 ExperienceLisa Malter, Simon J Hong, Sarah Lopatin, et al.Journal of Crohn'S & Colitis|April 9, 2020
Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical OutcomesBritt Christensen, Stephen B Hanauer, Peter R Gibson, et al.ACG Case Reports Journal|August 15, 2018
Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab InfusionJingzhou Wang, Arvin Bhatia, Noa Krugliak Cleveland, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 5, 2022
Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary CenterNathaniel A Cohen, David Choi, Tenzin Choden, et al.Journal of Managed Care & Specialty Pharmacy|April 12, 2021
Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visitA Mark Fendrick, Diana Brixner, David T Rubin, et al.Academic Radiology|June 16, 2009
Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot studyAytekin Oto, Xiaobing Fan, Devkumar Mustafi, et al.Digestive Diseases and Sciences|May 29, 2024
Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn's Disease: Real World Data from a Tertiary CenterNathaniel A Cohen, Tenzin Choden, Emma C Dyer, et al.Journal of Crohn'S & Colitis|February 23, 2018
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2Brian G Feagan, David Schwartz, Silvio Danese, et al.Inflammatory Bowel Diseases|February 23, 2013
Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease centerAtsushi Sakuraba, Kian Keyashian, Chase Correia, et al.Pageof 48